-
Editorial
March 31, 2025
- Editorial for JUO 2025 Vol. 23 No. 1 - Highlights of This Issue’s Papers and the JUO Editors’ Pick
- Cheol Kwak
- J Urol Oncol. 2025;23(1):1-3.
Editorial
March 31, 2025
Invited Review
March 31, 2025
Original Article
March 31, 2025
Original Article
March 31, 2025
Original Article
March 31, 2025
Invited Review
March 31, 2025
Original Article
March 31, 2025
Original Article
March 31, 2025
Invited Review
March 31, 2025
Original Article
March 31, 2025
Original Article
March 31, 2025
This archive contains links to the full-text of all issues.
![]() |
7,511 | Complex Epidemiology of Prostate Cancer in Asian Countries |
5,561 | Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023 |
5,091 | Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type |
4,822 | Current Update on Prostate Cancer Immunotherapy |
4,142 | Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up |
Cited By 12 |
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades |
Cited By 11 |
Complex Epidemiology of Prostate Cancer in Asian Countries |
Cited By 5 |
Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review |
Cited By 5 |
Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion |
Cited By 4 |
A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening |